- Home
- SAIH vs NRXS Comparison
SAIH vs NRXS Comparison
Compare SAIH & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAIH
- NRXS
- Stock Information
- Founded
- SAIH 2019
- NRXS 2011
- Country
- SAIH Singapore
- NRXS United States
- Employees
- SAIH N/A
- NRXS N/A
- Industry
- SAIH
- NRXS
- Sector
- SAIH
- NRXS
- Exchange
- SAIH NYSE
- NRXS Nasdaq
- Market Cap
- SAIH 22.4M
- NRXS 20.3M
- IPO Year
- SAIH N/A
- NRXS 2023
- Fundamental
- Price
- SAIH $0.91
- NRXS $3.15
- Analyst Decision
- SAIH
- NRXS
- Analyst Count
- SAIH 0
- NRXS 0
- Target Price
- SAIH N/A
- NRXS N/A
- AVG Volume (30 Days)
- SAIH 592.7K
- NRXS 23.3K
- Earning Date
- SAIH 11-22-2024
- NRXS 11-12-2024
- Dividend Yield
- SAIH N/A
- NRXS N/A
- EPS Growth
- SAIH N/A
- NRXS N/A
- EPS
- SAIH N/A
- NRXS N/A
- Revenue
- SAIH $6,954,000.00
- NRXS $2,456,219.00
- Revenue This Year
- SAIH N/A
- NRXS $383.16
- Revenue Next Year
- SAIH N/A
- NRXS N/A
- P/E Ratio
- SAIH N/A
- NRXS N/A
- Revenue Growth
- SAIH N/A
- NRXS N/A
- 52 Week Low
- SAIH $0.54
- NRXS $2.00
- 52 Week High
- SAIH $1.80
- NRXS $3.89
- Technical
- Relative Strength Index (RSI)
- SAIH N/A
- NRXS 59.42
- Support Level
- SAIH N/A
- NRXS $2.25
- Resistance Level
- SAIH N/A
- NRXS $3.78
- Average True Range (ATR)
- SAIH 0.00
- NRXS 0.42
- MACD
- SAIH 0.00
- NRXS 0.07
- Stochastic Oscillator
- SAIH 0.00
- NRXS 63.58
About SAIH SAIHEAT LIMITED
Saiheat Ltd develops technologies for the advanced Computing Center Ecosystem (ACCE), a next-gen computing center featuring high-performance servers, advanced liquid cooling, and systems for capturing and recycling computing heat. It aims to reduce the carbon footprint of Bitcoin mining and AI operations.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).